MCID: HMR023
MIFTS: 41

Hemorrhagic Cystitis

Categories: Nephrological diseases

Aliases & Classifications for Hemorrhagic Cystitis

MalaCards integrated aliases for Hemorrhagic Cystitis:

Name: Hemorrhagic Cystitis 12 56 15 74

Classifications:



External Ids:

Disease Ontology 12 DOID:0050859
UMLS 74 C0085692

Summaries for Hemorrhagic Cystitis

Disease Ontology : 12 A cystitis that is characterized by dysuria, hematuria and hemorrhage located in the lower urinary tract.

MalaCards based summary : Hemorrhagic Cystitis is related to cystitis and hematopoietic stem cell transplantation. An important gene associated with Hemorrhagic Cystitis is IL11 (Interleukin 11), and among its related pathways/superpathways are DREAM Repression and Dynorphin Expression and Apoptosis and survival Caspase cascade. The drugs Cyclophosphamide and Prednisone have been mentioned in the context of this disorder. Affiliated tissues include bone, bone marrow and liver.

Wikipedia : 77 Hemorrhagic cystitis or haemorrhagic cystitis is an inflammation of the bladder defined by lower urinary... more...

Related Diseases for Hemorrhagic Cystitis

Diseases related to Hemorrhagic Cystitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 67)
# Related Disease Score Top Affiliating Genes
1 cystitis 11.2
2 hematopoietic stem cell transplantation 10.7
3 leukemia 10.2
4 epilepsy, familial temporal lobe, 2 10.2 IL11 PARP1
5 drug-induced hearing loss 10.1 HMOX1 JUN
6 graft-versus-host disease 10.1
7 lymphoma 10.1
8 herpes simplex 10.1
9 campylobacteriosis 10.1 JUN TLR4
10 bladder transitional cell papilloma 10.0 CYCS PARP1
11 systemic lupus erythematosus 10.0
12 leukemia, acute lymphoblastic 10.0
13 lymphocytic leukemia 10.0
14 lupus erythematosus 10.0
15 amelanotic melanoma 10.0 CYCS PARP1
16 prostate cancer 9.9
17 vesicoureteral reflux 1 9.9
18 prostate cancer, hereditary, 8 9.9
19 aplastic anemia 9.9
20 prostate cancer, hereditary, 6 9.9
21 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 9.9
22 thalassemia 9.9
23 encephalitis 9.9
24 toxic encephalopathy 9.9 CYCS HMOX1
25 bladder cancer 9.8
26 breast cancer 9.8
27 hepatocellular carcinoma 9.8
28 rheumatoid arthritis 9.8
29 ataxia-telangiectasia 9.8
30 fanconi anemia, complementation group a 9.8
31 lymphoma, hodgkin, classic 9.8
32 myeloma, multiple 9.8
33 neutrophil actin dysfunction 9.8
34 spondylocarpotarsal synostosis syndrome 9.8
35 urinary tract infections, recurrent 9.8
36 sickle cell anemia 9.8
37 granulomatosis with polyangiitis 9.8
38 acute promyelocytic leukemia 9.8
39 acute lymphocytic leukemia 9.8
40 arthritis 9.8
41 malignant glioma 9.8
42 thrombocytopenia 9.8
43 interstitial nephritis 9.8
44 hydronephrosis 9.8
45 sarcoma 9.8
46 urethritis 9.8
47 interstitial cystitis 9.8
48 pleuropneumonia 9.8
49 prostatitis 9.8
50 melanoma 9.8

Graphical network of the top 20 diseases related to Hemorrhagic Cystitis:



Diseases related to Hemorrhagic Cystitis

Symptoms & Phenotypes for Hemorrhagic Cystitis

Drugs & Therapeutics for Hemorrhagic Cystitis

Drugs for Hemorrhagic Cystitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 121)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 6055-19-2, 50-18-0 2907
2
Prednisone Approved, Vet_approved Phase 4,Phase 2,Phase 3 53-03-2 5865
3 Antineoplastic Agents, Alkylating Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
4 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
5 Immunologic Factors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
6 Alkylating Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
7 Antirheumatic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
8 Immunoglobulin A Phase 4,Phase 3
9 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1
10 Hormones Phase 4,Phase 3,Phase 2,Phase 1
11 Angiotensin-Converting Enzyme Inhibitors Phase 4
12 Antineoplastic Agents, Hormonal Phase 4,Phase 3,Phase 2,Phase 1
13 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1
14 glucocorticoids Phase 4,Phase 3,Phase 2,Phase 1
15 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1
16
Fludarabine Approved Phase 3,Phase 2,Phase 1 75607-67-9, 21679-14-1 30751
17
Vidarabine Approved, Investigational Phase 3,Phase 1,Phase 2 24356-66-9 21704 32326
18
Methylprednisolone hemisuccinate Approved Phase 3,Phase 2,Phase 1 2921-57-5
19
Methylprednisolone Approved, Vet_approved Phase 3,Phase 2,Phase 1 83-43-2 6741
20
Prednisolone Approved, Vet_approved Phase 3,Phase 2,Phase 1 50-24-8 5755
21
Prednisolone phosphate Approved, Vet_approved Phase 3,Phase 2,Phase 1 302-25-0
22
Azathioprine Approved Phase 2, Phase 3,Phase 3 446-86-6 2265
23
rituximab Approved Phase 2, Phase 3,Phase 3,Phase 1 174722-31-7 10201696
24
Sargramostim Approved, Investigational Phase 3,Phase 1,Phase 2 123774-72-1, 83869-56-1
25
Lenograstim Approved, Investigational Phase 3,Phase 2,Phase 1 135968-09-1
26
Mesna Approved, Investigational Phase 3,Phase 2,Phase 1 3375-50-6 598
27
Methotrexate Approved Phase 3 1959-05-2, 59-05-2 126941
28
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 1,Phase 2 22916-47-8 4189
29
Busulfan Approved, Investigational Phase 3,Phase 1,Phase 2 55-98-1 2478
30
Etoposide Approved Phase 3,Phase 1 33419-42-0 36462
31
leucovorin Approved Phase 3 58-05-9 6006 143
32
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3 59-30-3 6037
33
Prednisolone hemisuccinate Experimental Phase 3,Phase 2,Phase 1 2920-86-7
34 Antiviral Agents Phase 3,Phase 2,Phase 1,Not Applicable
35 Antimetabolites Phase 3,Phase 2,Phase 1
36 Anti-Infective Agents Phase 3,Phase 2,Phase 1,Not Applicable
37 Antimetabolites, Antineoplastic Phase 3,Phase 2,Phase 1
38 Thymoglobulin Phase 3,Phase 2,Phase 1
39 Antilymphocyte Serum Phase 3,Phase 2,Phase 1
40 Calcineurin Inhibitors Phase 3,Phase 2
41 Methylprednisolone Acetate Phase 3,Phase 2,Phase 1
42 Prednisolone acetate Phase 3,Phase 2,Phase 1
43 Peripheral Nervous System Agents Phase 2, Phase 3,Phase 3,Phase 1
44 Antineoplastic Agents, Immunological Phase 2, Phase 3,Phase 3,Phase 1
45 Autonomic Agents Phase 2, Phase 3,Phase 3,Phase 1
46 Antiemetics Phase 2, Phase 3,Phase 3,Phase 1
47 Protective Agents Phase 2, Phase 3,Phase 3,Phase 1
48 Gastrointestinal Agents Phase 2, Phase 3,Phase 3,Phase 1
49 Neuroprotective Agents Phase 2, Phase 3,Phase 3,Phase 1
50 Antibodies Phase 3,Phase 2,Phase 1

Interventional clinical trials:

(show all 34)
# Name Status NCT ID Phase Drugs
1 Extended Follow-up of Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy Active, not recruiting NCT03218852 Phase 4 prednisone and cyclophosphamide;prednisone alone
2 Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy Active, not recruiting NCT01758120 Phase 4 prednisone plus cyclophosphamide;Prednisone alone
3 Comparison of Cy-Atg vs Flu-Atg for the Conditioning Therapy in Allo-HCT for Adult Aplastic Anemia Unknown status NCT01145976 Phase 3 Cy-ATG;Flu-ATG
4 Cyclophosphamide for Acute Exacerbation of Idiopathic Pulmonary Fibrosis Recruiting NCT02460588 Phase 3 Cyclophosphamide;Placebo;Corticosteroid (prednisolone)
5 Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis Completed NCT00104299 Phase 2, Phase 3 Rituximab plus cyclophosphamide placebo (rituximab group);Cyclophosphamide plus rituximab placebo (control group);Azathioprine;Methylprednisolone (or other glucocorticoid);Prednisone
6 Maximizing Outcome of Multiple Sclerosis Transplantation Recruiting NCT03342638 Phase 3 Cyclophosphamide;Mesna;rATG;Methylprednisolone;G-CSF
7 Rituximab in Eosinophilic Granulomatosis With Polyangiitis Recruiting NCT02807103 Phase 3 Rituximab;Placebo-rituximab;Cyclophosphamide;Placebo-cyclophosphamide
8 Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial Recruiting NCT01445821 Phase 3 Cyclophosphamide;Mesna;rATG;Methylprednisolone;Filgrastim;Fludarabine
9 Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia Terminated NCT00002961 Phase 3 cyclophosphamide;cyclosporine;etoposide;methotrexate;Busulfan;Mesna
10 The Safety, Tolerability and Efficacy of LP-10 With Placebo in Subjects With Refractory Moderate to Severe Hemorrhagic Cystitis Unknown status NCT03129126 Phase 2 Placebo;LP-10
11 A Double Blind Randomized Study Using Placenta Derived Decidual Stromal Cells for Hemorrhagic Cystitis Unknown status NCT02174536 Phase 2
12 Cyclophosphamide in Myalgic Encephalopathy/ Chronic Fatigue Syndrome (ME/CFS) Unknown status NCT02444091 Phase 2 Cyclophosphamide
13 A Pilot Study Using Placenta Derived Decidual Stromal Cells for Hemorrhagic Cystitis Completed NCT02172963 Phase 1, Phase 2
14 Cidofovir Versus Best Supportive Care for Hemorrhagic Cystitis Active, not recruiting NCT01295645 Phase 2 Cidofovir
15 Efficacy and Safety of Activated Recombinant Human Factor VII in Refractory Haemorrhagic Cystitis Completed NCT01561352 Phase 2 activated recombinant human factor VII
16 Trial Evaluating the Efficacy of Systemic Mesenchymal Stromal Cell (MSC) Injections for the Treatment of Severe and Chronic Radiotherapy-induced Abdomino-pelvic Complications (Pelvic Radiation Disease, PRD) Refractory to Standard Therapy Not yet recruiting NCT02814864 Phase 2 Mesenchymal Stromal Cell (MSC) injections
17 Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases Completed NCT01336712 Phase 2
18 Third Party Anti-Viral Cytotoxic T-Cells Recruiting NCT02532452 Phase 2
19 Anti-viral Treatment Following Bone Marrow Transplant Recruiting NCT02048332 Phase 1, Phase 2
20 GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia Recruiting NCT02799147 Phase 1, Phase 2 Fludarabine monophosphate;Busulfan;Bendamustine
21 Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT Suspended NCT02627573 Phase 2 Busulfan;Fludarabine monophosphate;Tacrolimus;Mycophenolate mofetil;Cyclophosphamide;Thymoglobulin
22 BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance Terminated NCT02029638 Phase 2 Fludarabine;Cyclophosphamide;acetaminophen;diphenhydramine;methylprednisolone;MESNA;mycophenolate mofetil;prednisone;filgrastim
23 Efficacy of Durvalumab in Non-muscle-invasive Bladder Cancer Recruiting NCT03759496 Phase 2
24 Ruxolitinib for Steroid-refractory GVHD Recruiting NCT02997280 Phase 2 Ruxolitinib Oral Tablet
25 Liver Transplantation With Tregs at UCSF Not yet recruiting NCT03654040 Phase 1, Phase 2 cyclophosphamide;mesna;everolimus
26 Liver Transplantation With Tregs at MGH Recruiting NCT03577431 Phase 1, Phase 2 cyclophosphamide;mesna;everolimus
27 PTCy and Ruxolitinib GVHD Prophylaxis in Myelofibrosis Active, not recruiting NCT02806375 Phase 1, Phase 2 Busulfan;Fludarabine monophosphate;Cyclophosphamide;Ruxolitinib;Ruxolitinib
28 Stem Cell Transplantation for Stiff Person Syndrome (SPS) Active, not recruiting NCT02282514 Phase 1, Phase 2 Cyclophosphamide;Mesna;rATG;Methylprednisolone;G-CSF;Rituxan
29 HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide Active, not recruiting NCT02793544 Phase 2 Fludarabine;Cyclophosphamide 14.5 mg/kg/day IV on Days -6, -5;Busulfan;Cyclophosphamide 50mg/kg/day IV on Days -2,-1;Cyclophosphamide 50mg/kg/day IV on Days -5,-4;Post-HCT Cyclophosphamide 50mg/kg IV on Day+3, +4;Sirolimus;Mycophenolate mofetil;G-CSF;Pre-HCT Mesna on Days -6 and -5;Pre-HCT Mesna on Days -2 and -1;Pre-HCT Mesna on Days -5 and -4;Post-HCT Mesna
30 Intravesical Cidofovir for Hemorrhagic Cystitis Completed NCT01816646 Phase 1 Cidofovir;Probenecid
31 Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors Completed NCT00003141 Phase 1 carboplatin;cisplatin;cyclophosphamide;etoposide;thiotepa;vincristine sulfate
32 Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant Completed NCT00089453 Phase 1 Dexamethasone;Cyclophosphamide;Melphalan;Fludarabine;Bortezomide;Interleukin
33 Cidofovir Instillation in Hematopoietic Stem Cell Transplant (HSCT) Recipients With Hemorrhagic Cystitis Withdrawn NCT00956176 Not Applicable Cidofovir
34 Autologous Transplant Using Dose-Escalated Total Body Irradiation & Cyclophosphamide & Palifermin for NHL Recruiting NCT03042585 Not Applicable

Search NIH Clinical Center for Hemorrhagic Cystitis

Genetic Tests for Hemorrhagic Cystitis

Anatomical Context for Hemorrhagic Cystitis

MalaCards organs/tissues related to Hemorrhagic Cystitis:

42
Bone, Bone Marrow, Liver, Kidney, T Cells, Brain, Spinal Cord

The Foundational Model of Anatomy Ontology organs/tissues related to Hemorrhagic Cystitis:

20
The Lower Urinary Tract

Publications for Hemorrhagic Cystitis

Articles related to Hemorrhagic Cystitis:

(show top 50) (show all 551)
# Title Authors Year
1
Canadian Urological Association Best Practice Report: Diagnosis and management of radiation-induced hemorrhagic cystitis. ( 30721124 )
2019
2
IPSE, a urogenital parasite-derived immunomodulatory protein, ameliorates ifosfamide-induced hemorrhagic cystitis through downregulation of pro-inflammatory pathways. ( 30733505 )
2019
3
Critical role of mismatched HLA in hemorrhagic cystitis after haploidentical hematopoietic stem cell transplant. ( 30735721 )
2019
4
IPSE, a parasite-derived host immunomodulatory protein, is a potential therapeutic for hemorrhagic cystitis. ( 30785353 )
2019
5
Scoping Review and Meta-analysis of Hyperbaric Oxygen Therapy for Radiation-Induced Hemorrhagic Cystitis. ( 29654564 )
2018
6
BK Viremia as a Predictor of Hemorrhagic Cystitis in Adults During the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplantation. ( 29880378 )
2018
7
Alleviation of Cyclophosphamide-induced Hemorrhagic Cystitis by Dietary Pomegranate: A Comparative Experimental Study With Mesna. ( 29734214 )
2018
8
Severe BK polyomavirus-induced hemorrhagic cystitis in a kidney transplant recipient with the absence of renal allograft involvement. ( 29143415 )
2018
9
Hyperbaric oxygen as a treatment modality in cyclophosphamide-induced hemorrhagic cystitis. ( 29569791 )
2018
10
Hemorrhagic cystitis associated with gefitinib treatment: a case report. ( 29958970 )
2018
11
Placenta-Derived Decidua Stromal Cells for Hemorrhagic Cystitis after Stem Cell Transplantation. ( 29408819 )
2018
12
Comparison of intravenous or intravesical cidofovir in the treatment of BK polyomavirus-associated hemorrhagic cystitis following adult allogeneic stem cell transplantation-A systematic review. ( 29797613 )
2018
13
Intravesicular cidofovir for BK hemorrhagic cystitis in pediatric patients after hematopoietic stem cell transplant. ( 29388318 )
2018
14
Treatment of late-onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: the role of corticosteroids. ( 29532160 )
2018
15
High incidence of BK virus-associated hemorrhagic cystitis in children after second or third allogeneic hematopoietic stem cell transplantation. ( 29654658 )
2018
16
Hemorrhagic cystitis after hematopoietic stem cell transplantation: A challenge for the pediatric urologist. ( 29776868 )
2018
17
Equine idiopathic hemorrhagic cystitis: Clinical features and comparison with bladder neoplasia. ( 29604121 )
2018
18
Efficacy of Cidofovir in Treatment of BK Virus-Induced Hemorrhagic Cystitis in Allogeneic Hematopoietic Cell Transplant Recipients. ( 29679772 )
2018
19
Therapeutic exploitation of IPSE, a urogenital parasite-derived host modulatory protein, for chemotherapy-induced hemorrhagic cystitis. ( 29613835 )
2018
20
Successful induction of therapeutic urinary concentration by intravenous ganciclovir and oral valganciclovir with remission of adenoviral hemorrhagic cystitis after cord blood transplantation. ( 29885009 )
2018
21
Cytomegalovirus Hemorrhagic Cystitis in a Malignant Glioma Patient Treated with Temozolomide: A Case Report. ( 29780148 )
2018
22
Re: Safety and Efficacy of Intravesical Alum for Intractable Hemorrhagic Cystitis: A Contemporary Evaluation. ( 29783557 )
2018
23
Donor lymphocyte infusion for BK virus hemorrhagic cystitis and nephropathy: a case report. ( 30518978 )
2018
24
Superselective vesical artery embolization in the management of intractable hematuria secondary to hemorrhagic cystitis. ( 30560299 )
2018
25
Higher Incidence of Hemorrhagic Cystitis Following Haploidentical Related Donor Transplantation Compared with Matched Related Donor Transplantation. ( 30579967 )
2018
26
Cyclophosphamide-induced hemorrhagic cystitis in young patients with solid tumors: A single institution study. ( 29989294 )
2018
27
Neutrophils contribute to the pathogenesis of hemorrhagic cystitis induced by ifosfamide. ( 29990699 )
2018
28
A contemporary review about the management of radiation-induced hemorrhagic cystitis. ( 30015689 )
2018
29
Hemorrhagic Cystitis: Brighter Days Ahead. ( 30021128 )
2018
30
Excellent response of solifenacin in chemotherapy-induced hemorrhagic cystitis in a child with non-Hodgkin's lymphoma. ( 30112345 )
2018
31
Cancer survivorship issues with radiation and hemorrhagic cystitis in gynecological malignancies. ( 30132277 )
2018
32
Re: Review of Advances in Uroprotective Agents for Cyclophosphamide- and Ifosfamide-Induced Hemorrhagic Cystitis. ( 30227545 )
2018
33
Hemorrhagic Cystitis: Treatment With Hyperbaric Oxygen Therapy in Patients With Acute Lymphoblastic Leukemia. ( 30451996 )
2018
34
Successful Treatment of BK Virus Hemorrhagic Cystitis (HC) Post Allogenic Hematopoietic Stem Cell Transplantation with Low Dose Cidofovir. ( 28598058 )
2017
35
Hemorrhagic Cystitis in a Liver Transplant Recipient Secondary to BK Virus. ( 28516112 )
2017
36
Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic Cystitis. ( 28744284 )
2017
37
Conjugated Estrogen in Late-Onset Hemorrhagic Cystitis Associated with Hematopoietic Stem Cell Transplantation. ( 28286609 )
2017
38
Incidence and risk factor of hemorrhagic cystitis after allogeneic transplantation with fludarabine, busulfan, and anti-thymocyte globulin myeloablative conditioning. ( 28199755 )
2017
39
Nosocomial BK Polyomavirus Infection Causing Hemorrhagic Cystitis Among Patients With Hematological Malignancies After Hematopoietic Stem Cell Transplantation. ( 28295968 )
2017
40
Treatment of a Pediatric Case of Severe Hemorrhagic Cystitis: Case Report and Review of Literature. ( 29198679 )
2017
41
BK Virus-associated Hemorrhagic Cystitis in Patients with Allogeneic Hematopoietic Cell Transplantation: Report of Three Cases. ( 28702160 )
2017
42
Interventions to treat hemorrhagic cystitis: a systematic review and meta-analysis. ( 28462435 )
2017
43
Viral-induced Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplant. ( 28559150 )
2017
44
The Association of Combined GSTM1 and CYP2C9 Genotype Status with the Occurrence of Hemorrhagic Cystitis in Pediatric Patients Receiving Myeloablative Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation. ( 28744217 )
2017
45
Bladder Rupture After Chronic Hemorrhagic Cystitis in a Stem Cell Transplantation Recipient. ( 28471873 )
2017
46
Rare Cyclophosphamide-Induced Hemorrhagic Cystitis in a Chinese Population with Rheumatic Diseases. ( 28646351 )
2017
47
Dynamics of BKPyV reactivation and risk of hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation. ( 28401591 )
2017
48
Nationwide survey of BK polyomavirus associated hemorrhagic cystitis in adult allogeneic stem cell transplantation among haematologists and urologists. ( 28160087 )
2017
49
Intravesical formalin for hemorrhagic cystitis: A contemporary cohort. ( 28360951 )
2017
50
Treatment of Severe Refractory Hematuria due to Radiation-Induced Hemorrhagic Cystitis with Dexamethasone. ( 28713429 )
2017

Variations for Hemorrhagic Cystitis

Expression for Hemorrhagic Cystitis

Search GEO for disease gene expression data for Hemorrhagic Cystitis.

Pathways for Hemorrhagic Cystitis

Pathways related to Hemorrhagic Cystitis according to GeneCards Suite gene sharing:

(show all 16)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.17 CYCS JUN PARP1
2
Show member pathways
11.96 CYCS JUN PARP1
3
Show member pathways
11.9 CYCS JUN TLR4
4
Show member pathways
11.76 IL11 JUN TLR4
5
Show member pathways
11.59 CYCS JUN PARP1
6 11.3 CYCS TLR4
7
Show member pathways
11.24 CYCS PARP1
8 11.09 IL11 JUN TLR4
9 11.05 HMOX1 TLR4
10 11.03 HMOX1 JUN
11 10.92 CYCS JUN
12 10.81 HMOX1 JUN
13 10.77 CYCS PARP1
14 10.75 CYCS JUN PARP1
15 10.34 JUN TLR4
16 9.23 CYCS PARP1

GO Terms for Hemorrhagic Cystitis

Biological processes related to Hemorrhagic Cystitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 positive regulation of smooth muscle cell proliferation GO:0048661 9.4 HMOX1 JUN
2 response to hydrogen peroxide GO:0042542 9.37 HMOX1 JUN
3 cellular response to cadmium ion GO:0071276 9.32 HMOX1 JUN
4 negative regulation of DNA binding GO:0043392 9.26 HMOX1 JUN
5 cellular response to amyloid-beta GO:1904646 9.16 PARP1 TLR4
6 positive regulation of transcription by RNA polymerase II GO:0045944 9.02 IL11 JUN PARP1 TAF9 TLR4
7 regulation of DNA-binding transcription factor activity GO:0051090 8.96 HMOX1 JUN

Molecular functions related to Hemorrhagic Cystitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 protein binding GO:0005515 9.65 CYCS HMOX1 IL11 JUN PARP1 PPIG
2 activating transcription factor binding GO:0033613 9.16 JUN TAF9
3 R-SMAD binding GO:0070412 8.62 JUN PARP1

Sources for Hemorrhagic Cystitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....